Search Within

James Eastham

Formats
  1. Journal Article (389)
  2. Meeting Abstract (102)
  3. Book Section (15)
  4. Guidelines (10)
  5. Review (10)
  6. Editorial (6)
  7. Correspondence (4)
  8. Research Letter (2)
  9. Book Whole (1)
  10. Conference Paper (1)
Groups
  1. Surgery (540)
  2. Urology (540)
  3. Molecular Pharmacology and Chemistry Program Faculty (305)
  4. Sloan Kettering Institute Faculty (305)
  5. Epidemiology and Biostatistics (201)
  6. Population Sciences Research Program (192)

More Groups

People
  1. Peter Scardino (288)
  2. Andrew Vickers (128)
  3. Karim Touijer (93)
  4. Victor Reuter (72)
  5. Vincent Laudone (67)
  6. Daniel Sjoberg (60)

More People

Years
  1. 2025 (7)
  2. 2024 (13)
  3. 2023 (16)
  4. 2022 (22)
  5. 2021 (20)
  6. 2020 (16)

More Years

Publications
  1. Journal of Urology (80)
  2. European Urology (55)
  3. Journal of Clinical Oncology (48)
  4. BJU International (44)
  5. Urology (26)
  6. European Urology, Supplements (24)

More Publications

Publishers
  1. Elsevier Science, Inc. (163)
  2. Wiley Blackwell (67)
  3. Elsevier Inc. (53)
  4. American Society of Clinical Oncology (48)
  5. European Association of Urology (24)
  6. Nature Publishing Group (23)

More Publishers

Results (540)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The quantification of GSP4 volume is superior to ISUP GG classification and %GSP4 for predicting adverse outcomes in radical prostatectomy patients
    Meeting Abstract

    Scuderi, S. L. A.; Tin, A.; Stabile, A.; Mazzone, E.; Quarta, L.; Zaurito, P.; Ciabattini, M.; Cosenza, A.; Brancaccio, M.; Leni, R.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant exercise therapy in prostate cancer: A phase 1, decentralized nonrandomized controlled trial
    Journal Article

    Jones, L. W.; Moskowitz, C. S.; Lee, C. P.; Fickera, G. A.; Chun, S. S.; Michalski, M. G.; Stoeckel, K.; Underwood, W. P.; Lavery, J. A.; Bhanot, U.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Quantification of Gleason pattern 4 metrics identifies pathologic progression in patients with grade group 2 prostate cancer on active surveillance
    Journal Article

    Perera, M.; Assel, M.; Nalavenkata, S.; Khaleel, S.; Benfante, N.; Carlsson, S. V.; Reuter, V. E.; Laudone, V. P.; Scardino, P. T.; Touijer, K. A.; more...
    Clinical Genitourinary Cancer (2024)

    Fulltext@MSK | Save
  • The highest grade group does not drive the risk of recurrence when systematic and multiparametric magnetic resonance imaging (MRI)-targeted biopsies are discordant: Preliminary findings using radical prostatectomy pathology as a surrogate for MRI-targeted biopsy grade
    Journal Article

    Scuderi, S.; Pellegrino, F.; Tin, A.; Beech, B. B.; Gandaglia, G.; Stabile, A.; Eastham, J. A.; Montorsi, F.; Briganti, A.; Vickers, A. J.
    European Urology Focus (2024)

    Fulltext@MSK | Save
  • Prostate cancer, version 3.2024
    Guidelines

    Schaeffer, E. M.; Srinivas, S.; Adra, N.; An, Y.; Bitting, R.; Chapin, B.; Cheng, H. H.; D'Amico, A. V.; Desai, N.; Dorff, T.; more...
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Predictors of the conduct of nerve sparing during radical prostatectomy
    Meeting Abstract

    Thorogood, S. L.; Liso, N.; Eastham, J.; Laudone, V.; Mulhall, J. P.; Flores, J. M.
    Journal of Sexual Medicine (2024)

    Fulltext@MSK | Save
  • Implementation and validation of an automated, longitudinal robotic surgical evaluation and feedback program at a high-volume center and impact on training
    Journal Article

    Wilcox Vanden Berg, R. N.; Vertosick, E. A.; Sjoberg, D. D.; Cha, E. K.; Coleman, J. A.; Donahue, T. F.; Eastham, J. A.; Ehdaie, B.; Laudone, V. P.; Pietzak, E. J.; more...
    European Urology Open Science (2024)

    Fulltext@MSK | Save
  • Do phosphodiesterase type 5 inhibitors increase the risk of biochemical recurrence after radical prostatectomy?
    Journal Article

    Flores, J. M.; Vertosick, E.; Jenkins, L. C.; Cooper, J.; Benfante, N.; Sjoberg, D.; Vickers, A. J.; Eastham, J. A.; Laudone, V. P.; Scardino, P. T.; more...
    Journal of Urology (2024)

    Fulltext@MSK | Save
  • Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial
    Journal Article

    Sumiyoshi, T.; Wang, X.; Warner, E. W.; Sboner, A.; Annala, M.; Sigouros, M.; Beja, K.; Mizuno, K.; Ku, S.; Fazli, L.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsy-proven radio-recurrent localized prostate cancer
    Journal Article

    McPherson, V.; Nair, S. M.; Tin, A. L.; Dewar, M.; Siddiqui, K.; Sjoberg, D. D.; Vickers, A. J.; Eastham, J.; Chin, J. L.
    CUAJ-Canadian Urological Association Journal (2024)

    Fulltext@MSK | Save